# Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia

> **NCT00003729** · PHASE2 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 13 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** cytarabine
- **DRUG:** fludarabine phosphate
- **DRUG:** idarubicin

## Key facts

- **NCT ID:** NCT00003729
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1998-12
- **Primary completion:** 2002-04
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2012-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003729, "Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*